1-[N-(4-NITROPHENYLMETHYL)-PIPERAZINYL-2-ETHYLAMIDO]-N-BENZYLOXY-CARBONYL-S-GLUTAMIC-ACID-5-ETHYLESTER
Compound with spectra: 1 NMR
![1-[N-(4-NITROPHENYLMETHYL)-PIPERAZINYL-2-ETHYLAMIDO]-N-BENZYLOXY-CARBONYL-S-GLUTAMIC-ACID-5-ETHYLESTER](/api/compound/1jUd3M2Fjwj.png?ph=true&h=300&w=458 "1-[N-(4-NITROPHENYLMETHYL)-PIPERAZINYL-2-ETHYLAMIDO]-N-BENZYLOXY-CARBONYL-S-GLUTAMIC-ACID-5-ETHYLESTER")
| SpectraBase Compound ID | 1jUd3M2Fjwj |
|---|---|
| InChI | InChI=1S/C28H37N5O7/c1-2-39-26(34)13-12-25(30-28(36)40-21-23-6-4-3-5-7-23)27(35)29-14-15-31-16-18-32(19-17-31)20-22-8-10-24(11-9-22)33(37)38/h3-11,25H,2,12-21H2,1H3,(H,29,35)(H,30,36)/t25-/m1/s1 |
| InChIKey | VAWUWHDPWDMFFH-RUZDIDTESA-N |
| Mol Weight | 555.6 g/mol |
| Molecular Formula | C28H37N5O7 |
| Exact Mass | 555.269299 g/mol |
| Enantiomer InChIKey | VAWUWHDPWDMFFH-VWLOTQADSA-N |
| Racemate InChIKey | VAWUWHDPWDMFFH-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(phenylmethyl) N-[1,5-bis[heptyl(methyl)amino]-1,5-bis(oxidanylidene)pentan-2-yl]carbamate
METHYL-N-(BENZYLOXYCARBONYL)-EPSILON-N-(HYDROCHLORIDE)-ORNITHYLLEUCINE
benzyl (1S)-1-({[(1S)-2-amino-1-benzyl-2-oxoethyl]amino}carbonyl)butylcarbamate
N-Carbobenzoxyleucyl-leucyl-glycine
N-[(N2-benzyloxycarbonyl-N4-nitro)-L-arcinyl]-L-valine
(phenylmethyl) N-[1-[2-(4-cyclohexylphenoxy)ethylamino]-1-oxidanylidene-3-phenyl-propan-2-yl]carbamate
Alaninamide, N-[(phenylmethoxy)carbonyl]-L-isoleucyl-N,N,2-trimethyl-
METHYL-N-(BENZYLOXYCARBONYL)-METHIONYLALANYLALANINE
N-(N-carboxy-L-leucyl)-L-isoleucine, N-benzyl ester
BENZYLOXYCARBONYL-VALINE-(TERT-BUTYLOXYCARBONYL)LYSINE DIPEPTIDE
| Title | Journal or Book | Year |
|---|---|---|
| Lipase-catalysed synthesis of new acetylcholinesterase inhibitors: N-benzylpiperidine aminoacid derivatives | Bioorganic & Medicinal Chemistry | 2000 |